Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

09:15 ET Jaguar Animal Health Announces Positive Preliminary Topline Results of Two Chinese-sponsored Farm Studies to Evaluate the Safety and Effectiveness of Neonorm Botanical Extract in Piglets

 Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), an animal health company focused on developing and commercializing...


09:00 ET Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Ultra-Short 785nm Wavelength

 Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today that the PicoWay® picosecond laser...


09:00 ET Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA

 Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it has resumed the enrollment and dosing of patients in its ongoing Phase 1b...


08:56 ET Un nuevo estudio confirma la correlación de las bacterias comunes (incluida la MRSA) y el eczema

Un nuevo estudio publicado en el British Journal of Dermatology[1] ha mostrado que, de media, el 70 % de los pacientes de eczema están...


08:28 ET ProTrials Research, Inc. Selected by Calithera Biosciences, Inc. for Early Phase Clinical Trial Support

 ProTrials Research, Inc., a leader in the clinical research organization (CRO) industry, announced today the awarding and initiation of an...


08:00 ET Vtesse Secures Additional $17 Million in Series A Extension to Support Further Product Development and Expand the Ongoing Clinical Trial of VTS-270 for the Treatment of Niemann-Pick Type C1 Disease

 Vtesse, Inc., a company committed to developing drugs that will benefit patients with extremely rare, life-threatening diseases, announced...


08:00 ET Eiger BioPharmaceuticals Announces First Patient Dosed in Phase 2 ULTRA Study of Ubenimex in Secondary Lymphedema

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced...


08:00 ET Vtesse amplía la financiación de su ensayo clínico VTS-270 para el tratamiento de Niemann-Pick de tipo C1

- Vtesse asegura 17 millones de dólares adicionales en ampliación de serie A para apoyar el desarrollo de producto y expandir el ensayo...


07:30 ET FDA Lifts Clinical Hold On CGF166

GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, announced today that it was notified by its collaborator, Novartis, that the...


07:00 ET Citius Pharmaceuticals Addresses Problem That Affects 10 Million People in the U.S.: Hemorrhoids

 Citius Pharmaceuticals, Inc. ("Citius") (OTC BB: CTXR), a specialty pharmaceutical company dedicated to acquiring, developing and...


07:00 ET Can-Fite Completes Phase II Study Design for CF102 in the Treatment of NASH/NAFLD

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being...


06:59 ET AbbVie and Bristol-Myers Squibb Announce Oncology Clinical Collaboration to Evaluate the Combination of Rova-T plus Opdivo and Opdivo + Yervoy Regimen

 AbbVie (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE:BMY) today announced a clinical trial collaboration to evaluate the safety,...


06:00 ET ImmunoCellular Therapeutics Reports Progress in Two Lead Cancer Immunotherapy Programs

 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today reported progress in its two lead cancer immunotherapy clinical...


02:01 ET Merrimack Announces ONIVYDE® Regimen Receives Positive CHMP Opinion in European Union

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...


02:00 ET ONIVYDE® Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Following Gemcitabine Based Therapy

The positive opinion is based on a pivotal Phase 3 study showing that ONIVYDE combined with chemotherapy significantly increased overall...


01:00 ET Araim Pharmaceuticals Obtains Fourth Orphan Designation: ARA 290 Obtains US Orphan Drug Designation for Treatment to Increase Survival and Improve Functioning of Pancreatic Islets Following Transplantation

 Araim Pharmaceuticals, a clinical stage drug development company with a unique platform technology for activating post-injury tissue...


Jul 24, 2016, 08:00 ET Formal Education And Complex Work May Reduce The Negative Effects Of Bad Diet And Cerebrovascular Disease On Cognition

 Researchers from the Wisconsin Alzheimer's Disease Research Center and Wisconsin Alzheimer's Institute today presented new data that suggests...


Jul 22, 2016, 13:43 ET Resverlogix anuncia la dosificación a los primeros dos pacientes en programas renales y huérfanos ampliados

El comienzo de este ensayo de fase 1 farmacocinético (PK) en pacientes con deterioro renal severo es el primero de una serie de ensayos...


Jul 22, 2016, 09:00 ET Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops

 Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to making drugs affordable again through its Branded...


Jul 22, 2016, 02:00 ET Valeant Pharmaceuticals Receives Complete Response Letter From The FDA

No Safety or Efficacy Concerns or Additional Clinical Trials Identified for Approval of Latanoprostene Bunod FDA Letter Related to CGMP at Bausch...


Jul 22, 2016, 01:00 ET Amgen And UCB Submit Biologics License Application For Romosozumab To The FDA

 Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced the submission of a Biologics License Application (BLA) to the U.S. Food...


Jul 21, 2016, 14:39 ET ViaCyte Awarded New CIRM Grant to Develop PEC-Direct for High-Risk Type 1 Diabetes

ViaCyte, Inc., a privately-held regenerative medicine company, today announced that the California Institute for Regenerative Medicine (CIRM)...


Jul 21, 2016, 14:35 ET Resverlogix Announces Dosing of First Two Patients in Expanded Renal and Orphan Programs

The commencement of this Phase 1 pharmacokinentic (PK) trial in patients with severe renal impairment is the first in a series of planned clinical...